Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.

Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn, Birgit S Geurts, Ilse A C Spiekman, Florentine A J Verbeek, Hans Timmer, Maud A van Maren, V van der Noort, Miguel Parra-Martinez, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Serena Marchetti, Kim Monkhorst